Ra Pharmaceuticals, Inc.·4

Oct 17, 8:11 PM ET

Ricardo Alonso 4

4 · Ra Pharmaceuticals, Inc. · Filed Oct 17, 2019

Insider Transaction Report

Form 4
Period: 2019-10-17
Ricardo Alonso
See Remarks
Transactions
  • Sale

    COMMON STOCK

    2019-10-17$46.70/sh2,285$106,7106,858 total
Footnotes (1)
  • [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2019.

Documents

1 file
  • 4
    a4.xmlPrimary

    4